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Earlier Detection of Antiphospholipid Syndrome 
 
Abstract 
A 52-year-old man is sitting at home watching a baseball game when all of a sudden the 
vision in both his eyes went black.  He described it as if someone pulled a “Venetian blind” over 
his eyes. He has a past medical history of aortic stenosis. He was taking Valsartan, Atorvastatin, 
B-12, Folic Acid, and Vitamin D-3 before the episode. He was prescribed Xarelto after the 
episode.  It was found that he had an optical stroke. Since the pressure in the eye was relieved, 
partial eyesight returned.  He now has full vision in his right eye, but only peripheral vision in his 
left eye.  At first it was believed that the stiffened valve must have thrown the clot and it just 
traveled to the eye, but since the cardiologist refused to believe that it was his valve the actual 
cause was discovered, antiphospholipid disorder.  It was found that the patient had elevated anti-
cardiolipin antibodies that caused the blood clot to form. The patient’s life as a whole is now 
altered completely due to a preventable thrombolytic event. His children also had to be tested 
because this disease has a genetic component so it is not only him that is affected by this.  If this 
man had been tested earlier for antiphospholipid syndrome then this whole event could have 
been avoided and his life would be different today.  
Antiphospholipid syndrome (APS) is a rare blood clotting disorder that affects about five 
people in 100,000 per year making it a rare disease (Lopes et al, 2017).  The National Heart, 
Lung, and Blood Institute (n.d.) currently lists the symptoms of antiphospholipid syndrome as 
deep vein thrombosis, unexplained pregnancy loss, stillbirth, stroke, and in some cases a rash. 
These symptoms are life-altering and in some cases even fatal.  Many times people who have 
antiphospholipid syndrome have to experience one of these significant events before they are 
even tested for the clotting disorder. If any of these symptoms are experienced it is advised you 
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seek emergency medical attention immediately.  This lists includes stroke, bleeding, pulmonary 
embolism, and deep vein thrombosis (“Antiphospholipid Antibody Syndrome | National Heart, 
Lung, and Blood Institute (NHLBI),” n.d.). 
The research question for this thesis is “How can we detect antiphospholipid disorder 
before it causes a life-altering event like a stroke or a miscarriage?”.  This topic is important to 
the nursing profession because it will condense the many articles available on antiphospholipid 
syndrome and its signs and symptoms into one main article that a health care professional can 
refer to for answers on antiphospholipid syndrome.  Studying detection of antiphospholipid 
disorder also has significance in the general community because it will raise awareness and also 
help to lower the rate of people having life-altering events due to this disease. The aim of this 
thesis is to provide a singular reference for professionals and the public to access when 
information on antiphospholipid disorder is needed.  In addition to the article there will be a 
patient teaching brochure to be handed out in doctors’ offices so that the information reaches 
actual patients.  
Background 
The role of phospholipids in the blood is to assist in the clotting process.  A person with 
APS creates antibodies that attack the phospholipids in the blood (“Antiphospholipid Antibody 
Syndrome | National Heart, Lung, and Blood Institute (NHLBI),” n.d.). There are several known 
risk factors such as autoimmune conditions (systemic lupus erythematous), certain infections 
like: syphilis, HIV/AIDS, Hepatitis C, Lyme disease, family history, pregnancy, immobility for 
extended periods of time, surgery, smoking tobacco, oral contraceptives or estrogen therapy, 
high cholesterol, and certain medications.  There are certain medications that can cause 
antiphospholipid syndrome, such as hydralazine for high blood pressure, quinidine for heart 
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dysrhythmias, and phenytoin for seizures, and amoxicillin, which is an antibiotic 
(“Antiphospholipid Antibody Syndrome | National Heart, Lung, and Blood Institute (NHLBI),” 
n.d.). 
There are many different terms for APS, but many times these different terms cause 
confusion.  One of the different terms for antiphospholipid disorder is lupus anticoagulant, which 
can give people the impression that only people with systemic lupus erythematous (SLE) or 
predominately the people with SLE have APS.  This is not the case. About half of 
antiphospholipid cases are not even associated with rheumatic diseases (Movva, Belilos, & 
Carsons, n.d.). While the exact prevalence of this disease is hard to determine, around 70% of the 
people diagnosed with APS are women (“Antiphospholipid Syndrome”, n.d.). Even though the 
disease is thought to have some genetic link most cases are sporadic, meaning they are present in 
an individual that has no prior family history of the disease (“Antiphospholipid syndrome”, n.d.). 
Cardiac Symptoms  
 One of the major life-altering complications from APS is myocardial infarction.  A 
myocardial infarction, or heart attack, is defined as blocked blood flow to the heart (“Heart 
Attack | National Heart, Lung, and Blood Institute (NHLBI),” n.d.).  This occurs when the blood 
clot blocks off a vessel completely and blood can no longer reach a certain part of the heart.  
Some common symptoms of a myocardial infarction are chest and/or arm pain that is described 
as pressure, aching, tightening or squeezing that can radiate to the neck, back or jaw, nausea, 
indigestion, heartburn, abdominal pain, shortness of breath, cold sweat, fatigue, and 
lightheadedness (“Heart Attack | National Heart, Lung, and Blood Institute (NHLBI),” n.d.). A 
heart attack can dramatically change the life of the patient. 
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 Heart disease and death from cardiac issues have been linked to abnormalities in aerobic 
capacity and autonomic nervous system modulation.  These abnormalities can be found in 
patients with autoimmune diseases like systemic lupus erythematous (SLE), primary 
antiphospholipid syndrome (PAPS) and rheumatoid arthritis.  Garcia et al ‘s (2013) study looked 
at PAPS patients’ heart rate recovery (HRR) compared to healthy patients’ HRR to measure 
aerobic capacity and cardiac autonomic control (Garcia et al., 2013).  The study also found lower 
VO2 peak (the amount of work the body produces measured by oxygen usage), time at 
ventilatory anaerobic threshold (VAT), time-to-exhaustion, and respiratory compensation point 
(RCP).  These findings are consistent with other rheumatologic diseases so this could be an 
important tool to diagnose or evaluate the risk of PAPS in patients (Garcia et al., 2013).   
APS causes multiple cardiac symptoms that can be caught prior to a myocardial 
infarction, but many physicians do not think to test for it because it is relatively rare 
(“Antiphospholipid syndrome,” n.d.). Increased suspicion of APS is one of the ways to increase 
detection of this disease.  APS has been known to damage a patient’s heart valves.  One of the 
valvular diseases linked to APS is Libman-Sacks valvulopathy (Lopes et al., 2017). Libman-
Sacks valvulopathy is a form of endocarditis that is not caused by a bacterium.  This endocarditis 
can cause any or all four valves (aortic, pulmonary, bicuspid, and tricuspid) to either develop 
stenosis, hardening of the valves, or regurgitation, backward flow of blood because of weak 
valves (Moaref, Afifi, Rezaian, & Rezaian, 2010).	Educating providers to investigate the causes 
of valve issues and endocarditis will help identify APS-related symptoms and make treatment 
more effective. It is difficult to pinpoint the cause of valvular disease because there are multiple 
causes so if a patient has multiple risk factors it becomes easy to blame one of the other risk 
factors and stop investigating.  
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There are other cardiac symptoms that can lead to the earlier diagnosis of APS.  Any kind 
of blood clot located somewhere in the body could be a symptom of APS and as such should be 
tested for in anyone with a past medical history of clots.  One type of blood clot that happens in 
the deep veins in one’s body, most commonly the legs, is called a deep vein thrombosis. Deep 
vein thrombosis is not life threatening alone, but they can dislodge from the leg and travel up to 
the lung where they can be life-threatening. Symptoms of a deep vein thrombosis are pain in the 
leg, redness or discoloration and a warm feeling in the affected leg (“Venous Thromboembolism 
| National Heart, Lung, and Blood Institute (NHLBI),” n.d.).  A deep vein thrombosis can cause a 
pulmonary embolism.  A pulmonary embolism is caused by the blockage of one of the 
pulmonary arteries.  The symptoms of a pulmonary embolism include shortness of breath, cough, 
and chest pain (“Venous Thromboembolism | National Heart, Lung, and Blood Institute 
(NHLBI),” n.d.).	Another blood clot is a portal vein thrombosis.  A portal vein thrombosis 
effects the blood supply to the liver and in turn causes the following symptoms: abdominal pain 
or distention, diarrhea, rectal bleeding, nausea, anorexia, fever, lactic acidosis, splenomegaly, 
and sepsis (Ponziani et al., 2010).  
Neurologic Symptoms 
Another life-threatening symptom of having APS is cerebrovascular infarction (stroke) or 
cerebrovascular accident (CVA). A stroke occurs when the blood supply to the brain is either 
interrupted or stopped depriving the brain of oxygen and nutrients (“NINDS Know Stroke 
Campaign - Know Stroke Brochure,” n.d.). The strokes seen from antiphospholipid syndrome 
usually occurs in young adults with no prior history of cardiovascular risk factors	(Lopes et al., 
2017). 
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There are other neurologic symptoms that are not life-threatening that can lead to the 
diagnosis of APS.  Some non-critical neurological symptoms of antiphospholipid syndrome are 
migraine, convulsions, and longitudinal myelitis (Lopes et al., 2017).  There are three autonomic 
nervous system disorders that have been linked to APS that have both cardiac symptoms and 
neurological symptoms.  They include postural orthostatic tachycardia (POTS), neurocardiogenic 
syncope (NCS) and neurogenic orthostatic hypotension (OH).  Postural orthostatic tachycardia 
manifests as dizziness, syncope, nausea, vomiting, headache, mental clouding, tremulousness, 
palpitations, chest pain, shortness of breath, and orthostatic hypotension.  Postural orthostatic 
tachycardia occurs mostly in women of reproductive age.  The symptoms of neurocardiogenic 
syncope are low blood pressure, low heart rate, pallor, diaphoresis (sweating), nausea, abdominal 
discomfort, yawning, and hyperventilation.  Neurogenic orthostatic hypotension is caused by an 
inability to properly vasoconstrict and/or the major fall in cardiac output (Schofield, Blitshteyn, 
Shoenfeld, & Hughes, 2014).  
 There have been two studies that looked at cerebrovascular events in the young adult 
population. Both articles consider a young adult to be someone who is younger than fifty when 
the thrombolytic event occurred.  These studies were created to look at the difference 
antiphospholipid syndrome can have on your likelihood to have a cerebrovascular event.  
Patients with APS were found to be five times more likely to have a cerebrovascular event than 
their unaffected counterparts.  Anticardiolipin antibody was also the most frequently detected 
antibody in the patients experiencing thrombolytic events with a rate of 22% of young stroke 
patients having it (Sciascia et al., 2015).  Sciascia et al. (2015) concluded that including 
antiphospholipid testing would not only improve the management of APS, but also the diagnosis. 
More awareness and knowledge needs to be spread about APS to help prevent or to help improve 
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the prognosis of these patients.  There was also a finding that anticardiolipin antibody (aCL) was 
associated with higher stroke or TIA rates in women and not in men (Mishra & Rohatgi, 2019).   
Obstetric Symptoms  
 Women tend to be effected by antiphospholipid syndrome more than men do 
(“Antiphospholipid syndrome,” n.d.).  This disease can affect women’s ability to bare healthy 
children.  APS can be linked to infertility and pregnancy complications.  Some obstetric 
symptoms of antiphospholipid syndrome are miscarriage or stillbirth, severe preeclampsia, 
unexplained fetal growth restriction, and chorea Gravidarum (Kochenour, Branch, Rote, & Scott, 
1987). Fischer-Betz, Specker, Brinks and Schneider’s (2018) study followed 24 pregnancies in 
20 women who had been diagnosed with a CVA due to APS from beginning to end.  One 
pregnancy was lost very early at four weeks and was excluded from the study.  Out of the 23 
remaining pregnancies two of them resulted in fetal death and eight mothers suffered from 
preeclampsia.  It was found that the mothers that tested positive for multiple antiphospholipid 
antibodies were at an increased risk for preeclampsia.  Four of the pregnancies had an abnormal 
second trimester Doppler ultrasound result and two of those were the aforementioned fetal 
demises (Fischer-Betz, Specker, Brinks, & Schneider, 2012).  This study found that there is also 
a higher rate of preterm delivery in mothers with antiphospholipid syndrome with the rate being 
26% compared to 4.7% and 19% in the controls (Fischer-Betz, Specker, Brinks, & Schneider, 
2012). Earlier investigation into the cause of fetal demise may help prevent additional 
miscarriages and stillbirths.  
Symptoms of Other Body Systems 
 There are some other body systems that are affected by APS.  One of them is the 
integumentary system or the skin.  Some cutaneous expressions of antiphospholipid are 
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cutaneous gangrene, necrosis of digits, livedo reticularis, lesions resembling vasculitis (nodules 
& macules), skin ulcerations, and thrombophlebitis  (Asherson & Cervera, 1993).  Sheth and 
Parke (2016) presented a case study that followed a woman that developed cutaneous vasculitis 
secondary to APS.  The case study was done on a 52-year-old woman with a significant past 
medical history of APS and HELLP  (hemolysis, elevated liver enzymes, low platelets) 
syndrome during pregnancy. The day after her wellness visit at the rheumatologist the patient 
was admitted to the ED with her chief complaint being an erythematous lesion on her chin, 
which quickly progressed into a dark red plaque.  Her vitals were stable and her lab work was 
within normal limits in the ED, but her physical exam revealed a small area of necrotic tissue and 
surrounding redness on her chin.  A biopsy was performed and the results showed that the patient 
was experiencing acute vasculitis.  She was started on 60 mg prednisone and her symptoms 
alleviated. A symptom of livedo reticularis is a mottled pattern that is a purple lace-like 
discoloration caused by the swelling of blood vessels.   This usually appears on the trunk, arms 
or legs and is not relieved by warming (Sheth & Parke, 2016).   
 Another body system that is affected by APS is the immune system.  In patients with 
APS it has been discovered that they are lacking an immunoregulatory cytokine called TGF-B1.  
This immunoregulatory cytokine is responsible for maintaining tolerance by limiting response to 
self-antigens (Jakiela et al., 2016).  In people who have a deficiency in the TGF-B1 
immunoregulatory cytokine they have enhanced activation of effector T-cells and this leads to 
severe autoimmunity.  It was even found that the higher the antiphospholipid (aPL) titers the 
more likely they are to have this reaction.  These patients do not display symptoms of having an 
autoimmune disorder, which makes them harder to diagnose.  (Jakiela et al., 2016)  Overall, the 
findings of the study found that the immunoregulatory cytokine network plays an important role 
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in the development of not only diseases like systemic lupus erythematosus (SLE) but also in 
primary antiphospholipid syndrome (PAP).  (Jakiela et al., 2016)  
The blood can also be affected by APS.  Thrombocytopenia can be caused by APS.  
Thrombocytopenia is a decreased number of platelets in the blood (“Antiphospholipid 
syndrome”, n.d.).  People with APS can also present as anemic, a shortage of red blood cells, 
which is caused by the destruction of red blood cells or hemolysis (“Antiphospholipid 
syndrome”, n.d.).  Some other hematologic disease that can be caused by APS are thrombotic 
thrombocytopenia purpura, sickle cell disease, polycythemia vera, myelofibrosis, Monoclonal 
gammopathies, and Von Willebrand’s disease (Asherson & Cervera, 1993). Thrombotic 
Thrombocytopenia Purpura (TTP) can be characterized by fever, confusion, dark or bloody 
urine, difficulty speaking, seizures, thrombocytopenia, weakness, and hemolytic anemia (Lewis, 
Bucher, Heitkemper, & Harding, 2017). 
The digestive system can also be affected by APS.  A case study was written on an 
individual that had multiple blood clots that had affected his gastrointestinal tract.  He presented 
to the ED complaining of abdominal pain, constipation, nausea, vomiting, and fatigue all lasting 
over a month.  Upon examination the patient looked frail and showed signs of weight loss.  He 
was treated for an obstruction and the symptoms seemed to subside besides the abdominal pain.  
The patient had a past medical history of end-to-end anastomosis of the small intestine for 
infarction and gangrene of two-thirds of the intestine.  The gangrene was thought to be caused by 
a blood clot in the mesenteric vein. The abdominal pain was investigated further with an 
abdominal computed tomography scan.  The scan found that there was a venous thrombosis in 
the inferior vena cava causing Budd-Chiari syndrome.  The patient returned two months later 
complaining of persistent abdominal pain, but this time there was distention that was present for 
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2 weeks.  The patient had lost a considerable amount of weight, pale conjunctivae without 
jaundice, ascites, mild pitting edema and splenomegaly (“The antiphospholipid antibody 
syndrome: a case report,” n.d.).  The patient continued to have blood-clotting episodes over the 
next few years until he became septic with a gangrenous scrotum. This patient was showing 
signs of a coagulation defect for approximately 6 years without further investigation.  If the 
doctors had suspected APS sooner this patient could have been spared years of agony and 
potential complications.  Diagnosing and treating APS can be costly to the patient so doctors are 
reluctant to run the tests if they don’t see good cause to (“The antiphospholipid antibody 
syndrome: a case report,” n.d.) 
Education 
 A reoccurring theme in the research on APS is that early detection yields better outcomes 
for patients and early detection can only happen if providers have a heightened awareness that 
APS should be tested for. Better education for providers and patients of will help. Patients and 
their families are generally overwhelmed with anxiety when they are in the hospital so they do 
not absorb or fully understand the information given to them so follow up education is very 
important. That is why it is important for staff to identify education programs that are effective, 
culturally sensitive, and accurate for the problem the patient is facing (DeMarco & Nystrom, 
2009).	There have been a few studies done to examine preferred method of teaching amongst 
patients. One study looked at the pros and cons of each teaching method so providers can pick 
the one they think fits their patient the best.  This study looked at traditional lectures, computer 
technology, written material, discussions, and simulated games as methods of education.  It was 
found that more patients were satisfied with computer-based learning, but there were concerns 
for retention over time with this method. Computer-based learning was also the preferred method 
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for children and adolescents showing an immediate knowledge increase (Friedman, Cosby, 
Boyko, Hatton-Bauer, & Turnbull, 2010).  Written information ranked high in patient 
satisfaction and information recall, but writing every patient an individual letter would create a 
lot of work for a busy physician.  Also written material needs to be at the reading level of the 
general population.  Booklets and informational packets helped to reduce the confusion patients 
were feeling and improved knowledge, especially if the information was provided before the first 
appointment (Friedman, Cosby, Boyko, Hatton-Bauer, & Turnbull, 2010).  Another study found 
that lectures and small group work was the most popular teaching method because it 
incorporated more than one teaching and/or learning methods into one teaching opportunity 
(Häggman-Laitila, Mattila, & Melender, 2016).  It is recommended that patients receive a lay 
version of their care plan because this enables them to better understand the plan of care. A lay 
version explains the goals of treatment, different treatment options and benefits and risks of each 
option.  Patients that have access to this are able to become active members of their treatment 
team and are better equipped for consultations with their health care provider (Schipper, Bakker, 
De Wit, Ket, & Abma, 2016). Education while the patient is in the hospital is very important, but 
it does not stop there. Patients need to have continuous education.  
 Patients with chronic diseases like antiphospholipid syndrome need to have continuous 
education in an outpatient setting while they learn to live with their disease. A clinic in 
Singapore has adopted an interesting plan for education in outpatient clinic settings. It is called 
the Plan-Do-Study-Act cycle. The cycle consisted of four interventions: development of health 
education slides, organization of a computer station and education materials, initiating an 
electronic appointment system for educational purposes and training for the staff on patient 
education materials to support self-care (Heng, Tham, Yoke Eng, Ling, & Menon, 2013).  
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Intervention one: development of health education slides consisted of developing a series of 
closely monitored and evaluated series of patient education slides. Intervention two: organization 
of a computer station and education materials suggest using shelving and other unused 
equipment in closed wards the display the health education that has been created. Intervention 
three: initiating an electronic appointment system for education purposes said that since the 
hospital already had Google applications for email they explored the appointment calendar 
feature with the help of the IT department. This did not cost the hospital any extra to implement. 
The last intervention, training for the staff on patient education materials to support self-care was 
achieved by sessions on patient education material with the Nurse Clinician (Heng, Tham, Yoke 
Eng, Ling, & Menon, 2013). Patients felt that the designated station for education was helpful, 
the electronic appointment calendar was easy to use and the training on education materials was 
clear and easy to understand. It is important for patients and family members to be comfortable 
using the educational materials because when they learn about their disease or loved one’s 
disease it helps them develop skills, build confidence and reduce any anxiety they are feeling 
(Heng, Tham, Yoke Eng, Ling, & Menon, 2013). 
Conclusion 
 Earlier detection of antiphospholipid syndrome is important to limit the adverse effects of 
the disease. Since most patients currently are not diagnosed until after they have a life-
threatening event, like a stroke or heart attack, many of them end up with disabilities related to 
that event. There are earlier symptoms of antiphospholipid syndrome that often go undiagnosed 
because they are either contributed to some other comorbidity or the cause is not investigated 
further. Antiphospholipid syndrome can affect multiple different body systems mostly the 
cardiac, neurological, and reproductive system. People who should be monitored for 
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antiphospholipid syndrome are people with a family history, any history of thrombolytic events, 
and obstetric complications without a previous explanation.  
 If a patient is experiencing any of the following symptoms they should be tested for 
antiphospholipid syndrome: depressed aerobic capacity, autonomic nervous system modulation, 
damaged heart valves, Libman-Sacks valvulopathy, any blood clot or migraine, convulsions, 
longitudinal myelitis, postural orthostatic tachycardia (POTS), neurocardiogenic syncope (NCS) 
and neurogenic orthostatic hypotension (OH), miscarriage or stillbirth, severe preeclampsia, 
unexplained fetal growth restriction, chorea Gravidarum, cutaneous gangrene, necrosis of digits, 
livedo reticularis, lesions resembling vasculitis (nodules & macules), skin ulcerations, 
thrombophlebitis, thrombocytopenia, thrombotic thrombocytopenia purpura, sickle cell disease, 
polycythemia vera, myelofibrosis, Monoclonal gammopathies, and Von Willebrand’s disease. 
Heightened suspicion of antiphospholipid syndrome is the key to catching it before it causes a 
life-changing event. Even though antiphospholipid syndrome is considered a rare disease, early 
diagnosis and treatment for patients with APS is crucial for quality of life and/or survival.  
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(APS) is a rare blood clotting 
disorder that affects about 5 
people in 100,000 per year 
making it a rare disease. A 
person with antiphospholipid 
syndrome creates antibodies 
that attack the phospholipids 
in the blood. It can cause 
blood clots to happen in 
people who are affected by 
this syndrome.1  
If you have more questions or concerns 
you can go to: 
− Mayo Clinic: 
Antiphospholipid Syndrome 
− Medscape.com and search 
antiphospholipid syndrome 








The information in this brochure is 
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Early Symptoms of Antiphospholipid Syndrome 
Cardiac Symptoms 
• Damaged heart valves 
• Libman-Sacks valvulopathy 
• Blood clots anywhere in the body 
and other symptoms4 
Obstetric Symptoms  
• Miscarriage or stillbirth 
• Severe preeclampsia 
• Unexplained fetal growth 
restriction 






What are the risk factors of 
antiphospholipid syndrome? 
Family history, autoimmune 
conditions (systemic lupus 
erythematous), certain infections 
like: syphilis, HIV/AIDS, Hepatitis 
C, Lyme disease, pregnancy, 
immobility for extended periods of 
time, surgery, smoking tobacco, 
oral contraceptives or estrogen 
therapy, high cholesterol, and 
certain medications (hydralazine 
for high blood pressure, quinidine 
for heart dysrhythmias, and 
phenytoin for seizures, and 
amoxicillin, which is an 
antibiotic).1. 
How do you treat APS? 
There is no treatment for APS, but 
patients will be put on an 
anticoagulant so that they will not 
develop blood clots.1 
Who does APS usually affect? 
While the exact prevalence of this 
disease is hard to determine, around 
70% of the people diagnosed with 
APS are women.  Also, if there is a 
family history their children are at 
risk for the disease. 1 
 
Hematologic Symptoms  
•  Inflammation and pain 
caused by a blood clot 
• Low platelet count 
• Sickle cell disease 
• Polycythemia vera 
• Myelofibrosis 
• Monoclonal gammopathies 




• Longitudinal myelitis and other 
symptoms1 
Integumentary Symptoms 
• Death of the skin from lack of 
blood flow 
• Blackening of the fingers 
• Skin lesions and other 
symptoms2  
